NTN Buzztime

Eterna Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Brooklyn ImmunoTherapeutics

Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) announced that it completed the reverse merger with NTN Buzztime. These are the details.

Brooklyn ImmunoTherapeutics Has Completed A Reverse Merger with NTN Buzztime

CARLSBAD, Calif., March 23, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) today announced that it plans to effect a one for two reverse stock split of its outstanding shares of common stock immediately prior to the closing of the merger with Brooklyn ImmunoTherapeutics LLC, which is anticipated to occur on March 25, 2021.

NTN Buzztime Announces Proposed Reverse Stock Split Ratio and Anticipated Closing of Merger

The stock price of NTN Buzztime Inc (NYSEAMERICAN: NTN) has increased by over 30% pre-market. This is why it happened.

NTN Stock Price Increases Over 30% Pre-Market: Why It Happened

CARLSBAD, Calif., March 15, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) today announced that its stockholders have approved the proposed merger between NTN and Brooklyn ImmunoTherapeutics LLC.

NTN Buzztime Announces Approval of Merger with Brooklyn ImmunoTherapeutics by Stockholders at Special Meeting

CARLSBAD, Calif., March 8, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN) today announced that leading independent proxy advisory firm Institutional Shareholder Services, Inc. ("ISS") recommends that NTN stockholders vote "FOR" ALL PROPOSALS to be considered and voted on at...

Independent Advisory Firm ISS Recommends NTN Stockholders Vote FOR Proposed Merger and Asset Sale and ALL Related Proposals

Ault Global Holdings, Inc (NYSE: DPW) acquired a 9.96% stake in NTN Buzztime, Inc (NYSE: NTN) for $1.01 million or $3.42 per share as of January 29. The purchase price signifies a 37.9% discount to NTN's Wednesday closing price.

Ault Global Purchases Minority Stake In NTN Buzztime To Stop Gaming Asset Divestment

CARLSBAD, Calif., Feb. 3, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN), today announced that its registration statement on Form S-4 relating to the proposed merger involving NTN and Brooklyn ImmunoTherapeutics LLC ("Brooklyn") and the proposed sale of NTN's assets to...

NTN Buzztime Announces Date of Special Meeting of Stockholders to Vote on Proposed Merger and Asset Sale

CARLSBAD, Calif., Jan. 15, 2021 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN), announced it received a letter from the NYSE Regulation stating that it is not in compliance with NYSE American LLC continued listing standards. Specifically, the Company is not in compliance with...

NTN Buzztime, Inc. Receives Noncompliance Notice from NYSE American

CARLSBAD, Calif., Nov. 13, 2020 /PRNewswire/ -- NTN Buzztime, Inc. (NYSE American: NTN), reported financial results for the third quarter ended September 30, 2020. "Buzztime is working diligently toward closing two transformative transactions," said Allen Wolff, CEO of NTN Buzztime....

NTN Buzztime, Inc. Reports Third Quarter 2020 Results

NTN Buzztime (NTN) is in the news Monday after an asset sale announcement with eGames.com Holdings put NTN stock on a wild ride.

NTN Buzztime News: NTN Stock Falls 2% Following Assets Sale

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq.

NTN BUZZTIME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of NTN Buzztime, Inc. - NTN

NEW YORK, Aug. 18, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of NTN Buzztime, Inc.

SHAREHOLDER ALERT: WeissLaw LLP Investigates NTN Buzztime, Inc.

NEW YORK--(BUSINESS WIRE)-- #Acquisition--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of NTN Buzztime, Inc.

NTN BUZZTIME ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of NTN and Encourages Investors to Contact the Firm

NEW YORK, Aug. 17, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating NTN Buzztime, Inc.

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of NTN Buzztime, Inc.- NTN

NTN Buzztime (NTN) is seeing massive gains for its stock on Thursday after announcing a merger deal with Brooklyn ImmunoTherapeutics LLC.
The post NTN Buzztime Stock Soars 181% on Merger Deal appeared first on InvestorPlace.

NTN Buzztime Stock Soars 181% on Merger Deal

NTN Buzztime (NYSE: NTN) shares are trading higher on Thursday after the company announced that its merger deal with Brooklyn ImminoTherapeutics was approved by shareholders.

Why NTN Buzztime's Stock Is Trading Higher Today

NTN Buzztime, Inc. (NTN) CEO Allen Wolf on Q1 2020 Results - Earnings Call Transcript

NTN Buzztime, Inc. (NTN) CEO Allen Wolff on Q4 2019 Results - Earnings Call Transcript

NTN Buzztime, Inc. (NTN) CEO on Q4 2019 Results - Earnings Call Transcript

NTN Buzztime, Inc. (NTN) Q3 2019 Results - Earnings Call Transcript

NTN Buzztime, Inc. (NTN) CEO Ram Krishnan on Q2 2019 Results - Earnings Call Transcript

NTN Buzztime, Inc. (NTN) CEO Ram Krishnan on Q1 2019 Results - Earnings Call Transcript

NTN Buzztime, Inc. (NTN) CEO Ram Krishnan on Q4 2018 Results - Earnings Call Transcript

News for NTN Buzztime Stock (NTN)